Theodore A C, Beer D J
Clin Chest Med. 1986 Dec;7(4):657-71.
The pharmacologic treatment of the reversible elements of chronic obstructive pulmonary disease is discussed in this article. Discussion focuses on three classes of bronchodilator drugs--the sympathomimetic agents, the methylxanthines, and the anticholinergic agents. A section on corticosteroid use in patients with chronic airflow limitation is included. An integrated approach to pharmacotherapy is suggested that allows a treatment program to be designed to meet the needs of the individual patient.
本文讨论了慢性阻塞性肺疾病可逆性因素的药物治疗。讨论集中在三类支气管扩张剂药物——拟交感神经药、甲基黄嘌呤类药物和抗胆碱能药物。其中还包括了关于慢性气流受限患者使用皮质类固醇的章节。本文建议采用综合药物治疗方法，以便设计出满足个体患者需求的治疗方案。
